Tropical PancreatitisTandon R.K.a · Garg P.K.b
aDepartment of Gastroenterology, Pushpawati Singhania Research Institute for Liver, Renal and Digestive Diseases, and bAll India Institute of Medical Sciences, New Delhi, India
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Tropical pancreatitis is a special type of chronic pancreatitis that is seen mainly in tropical countries. The prevalence of tropical pancreatitis is about 126/100,000 population in southern India. It occurs usually in young people, involves the main pancreatic duct and results in large ductal calculi. The etiology is not known, but genetic mutations such as the SPINK1 gene mutation and environmental factors are likely causes. Clinically, >90% of patients present with abdominal pain. About 25% of patients develop diabetes which generally requires insulin for its control but is ketosis-resistant. Painless diabetes is another clinical presentation in some patients. Most patients develop malnutrition during the course of the disease. Steatorrhea is less common. Patients with tropical pancreatitis may develop pancreatic cancer as a long-term complication. The diagnosis can be established by plain radiography of the abdomen, ultrasonography, computerized tomography scan of the abdomen or endoscopic retrograde cholangiopancreatography. Management is directed towards relief from pain and control of diabetes and steatorrhea. Pain relief can be obtained by analgesics and enzyme supplementation with preparations rich in proteases. Endotherapy coupled with stone fragmentation by extracorporeal shock wave lithotripsy is an effective therapy for those who fail to respond to medical therapy. Surgical decompression of the main pancreatic duct by lateral pancreato-jejunostomy is reserved for patients with severe pain non-responsive to other forms of therapy.
© 2004 S. Karger AG, Basel
Tandon RK: Tropical calcific pancreatitis. J Gastroenterol Hepatol 1998;13(suppl):S284–S248.
- Zuidema PJ: Cirrhosis and disseminated calcification of the pancreas in patients with malnutrition. Trop Geogr Med 1959;11:70–74.
Sarles H, Payan H, Sahel J: Chronic pancreatitis, relapsing pancreatitis and calcifications of pancreas. Gastroenterology 1976;3:1040–1051.
Diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser 1985;727:1–113.
Geeverghese PH: Pancreatic Diabetes: A Clinicopathological Study of Growth Onset Diabetes with Pancreatic Calculi. Bombay, Popular Prakastan, 1968.
- Balakrishnan V: Chronic calcific pancreatitis in the tropics. Ind J Gastroenterol 1984;3:65–67.
- Garg P, Tandon RK: Survey on chronic pancreatitis in the Asia-Pacific region. J Gastroenterol Hepatol 2004;19:998–1004.
- Balaji LN, Tandon RK, Tandon BN, Banks A: Prevalence and clinical features of chronic pancreatitis in southern India. Int J Pancreatol 1994;15:29–34.
- Copenhagen pancreatitis study. An interim report from a prospective epidemiological multicentre study. Scand J Gastroenterol 1981;16:305–312.
- Lin Y, Tamakoshi A, Matsuno S, Takeda K, Hayakawa T, Kitagawa M, Naruse S, Kawamura T, Wakai K, Aoki R, Kojima M, Ohno Y: Nationwide epidemiological survey of chronic pancreatitis in Japan. J Gastroenterol 2000;35:136–141.
- Chari ST, Mohan V, Pitchumoni CS, et al: Risk of pancreatic carcinoma in tropical calcifying pancreatitis. An epidemiological study. Pancreas 1994;9:62–66.
- Brooks SE, Golden MH: The exocrine pancreas in kwashiorkor and marasmus. Light and electron microscopy. West Indian Med J 1992;41:56–60.
- Balakrishnan V, Sauniere JF, Hariharan M, Sarles H: Diet, pancreatic function, and chronic pancreatitis in south India and France. Pancreas 1988;3:30–35.
Singh N, Sethi M, Garg PK, Joshi YK, Tandon RK: Malnutrition and chronic pancreatitis: A prospective study of cause and effect relationship. Indian J Gastroenterol 2002;21(suppl):A42.
- Barbezat GO, Hansen JDL: The exocrine pancreas and protein calorie malnutrition. Pediatrics 1968;42:77.
Narendranathan M: Chronic calcific pancreatitis of the tropics. Trop Gastroenterol 1981;2:40–45.
- Narendranathn M, Cheriyan A: Lack of association between cassava consumption and tropical pancreatitis syndrome. J Gastroenterol Hepatol 1994;9:282–285.
- Mathangi DC, Deepa R, Mohan V, Govindaranjan M, Namasivayam A: Long-term ingestion of cassava (tapioca) does not produce diabetes or pancreatitis in the rat model. Int J Pancreatol 2000;27:203–208.
- Braganza JM, Schofield D, Snehalatha C, Mohan V: Micronutrient antioxidant status in tropical compared with temperate-zone chronic pancreatitis. Scand J Gastroenterol 1993;28:1098–104.
- McCloy R: Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy. Digestion 1998;59(suppl 4):36–48.
Chouduary A, Garg PK, Tandon RK: The role of oxidative stress in tropical pancreatitis and effect of antioxidants supplementation on pain in patients with tropical pancreatitis (abstract). J Gastroenterol Hepatol 2001;16(suppl):A132.
- Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Urich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Umomo G, Post JC, Ehrich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141–145.
- Sanjeevi CB, Kanungo A, Shtanvera A, Samal KC, Tripathi BB: Association with HLA class II alleles with different subgroups of diabetes mellitus in eastern India identify different associations with IDDM and malnutrition related diabetes. Tissue Antigen 1999;54:83–87.
Rossi L, Whitcomb DC, Ehrich GD, et al: Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh. Pancreas 1998;54:83–87.
- Hassan Z, Mohan V, McDermott MF, et al: Pancreatitis in fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene. Diabetes Metab Res Rev 2000;16:454–457.
- Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645–652.
- Cohn JA, Friendman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653–658.
Makharia GM, Kabra M, Garg PK, Shastri SS, Tandon RK: Cystic fibrosis transmembrane conductance regulator gene mutations (ΔF508 and 3849+10KB C→T) in patients with chronic calcific pancreatitis of tropics. J Gastroenterol Hepatol 2001;(suppl)16:A112.
- Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213–216.
- Kaneko K, Nagasaki Y, Furukawa T, Mizutamari H, Sato A, Masamune A, et al: Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutation in Japanese patients with chronic pancreatitis. J Hum Genet 2001;46:293–297.
Rinderknecht H: Pancreatic secretory enzymes; in Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds): The Pancreas: Biology, Pathobiology and Disease, ed 2. New York, Raven Press, 1993, pp 219–251.
- Pfutzer RH, Barmada MM, Brunskil APJ, Finch R, Hart PS, Neoptolemos J, et al: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615–623.
- Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, Witt H: Tropical calcific pancreatitis: Strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 2002;123:1020–1025.
- Chandak GR, Idris MM, Reddy DN, Mani KR, Bhaskar S, Rao GV, Singh L: Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut 2004;53:723–728.
- Homma T, Harada H, Koizumi M: Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society. Pancreas 1997;15:14–15.
- Catalano MF, Lahoti S, Geenen JE, Hogan WJ: Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998;48:11–17.
- Mohan V, Nagalotimath SJ, Yajnik CS, Tripathy BB: Fibrocalculous pancreatic diabetes. Diabetes Metab Rev 1998;14:153–170.
- Sidhu SS, Shah P, Prasanna BM, Srikanta SS, Tandon RK: Chronic calcific pancreatitis of the tropics (CCPT): Spectrum and correlates of exocrine and endocrine pancreatic dysfunction. Diabetes Res Clin Pract 1995;27:127–132.
- Brown A, Hughes M, Tenner S, Banks PA: Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: A meta-analysis. Am J Gastroenterol 1997;92:2032–2035.
- Slaff J, Jacobson D, Tillman CR, et al: Protease specific suppression of pancreatic exocrine secretion. Gastroenterology 1984;87:44–52.
- Isaksson G, Ihse I: Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983;28:97–102.
- Warshaw AL, Banks PA, Fernandez-Del Castillo C: AGA technical review: Treatment of pain in chronic pancreatitis. Gastroenterology 1998;115;765–776.
- Tandon RK, Sato N, Garg PK: Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol 2002;17:508–518.
Nandi B, Garg PK, Bhardwaj P, Prakash S, Tandon RK: Efficacy of antioxidants for pain relief in patients with chronic pancreatitis: A randomized controlled trial. Ind J Gastroenterol 2002;21(suppl):A43.
- Sidhu SS, Nundy S, Tandon RK: The effect of the modified Puestow procedure on diabetes in patients with tropical chronic pancreatitis: A prospective study. Am J Gastroenterology 2001;96:107–111.
- Thomas PG, Augustine P, Ramesh H, Rangabashyam N: Observations and surgical management of tropical pancreatitis in Kerala and southern India. World J Surg 1990;14:32–42.
- Izbicki RJ, Bloechle C, Knoefel WT, Rogiers X, Kuechler T: Surgical treatment of chronic pancreatitis and quality of life after operation. Surg Clin North Am 1999;79:913–944.
- Delhaye M, Vandermeeren A, Baize M, et al: Extracorporeal shock-wave lithotripsy of pancreatic calculi. Gastroenterology 1992;102:610–620.
- Adamek HE, Jakobs R, Buttmann A, Adamek MU, Schneider AR, Riemann JF: Long term follow up of patients with chronic pancreatitis and pancreatic stones treated with extracorporeal shock wave lithotripsy. Gut 1999;45:402–405.
- Rosch T, Daniel S, Scholz M, et al: Endoscopic treatment of chronic pancreatitis: A multicenter study of 1000 patients with long-term follow-up. Endoscopy 2002;34:765–771.
Garg PK, Seth A, Gupta NP, Tandon RK: Endoscopic pancreatic sphincterotomy plus extracorporeal shock wave lithotripsy is effective treatment for tropical pancreatitis (abstract). J Gastroenterol Hepatol 2000;15(suppl):A204.
- Ammann RW, Akovbinatz A, Largiader F, et al: Course and outcome of chronic pancreatitis. Gastroenterology 1984;86:820–828.
- Dite P, Ruzicka M, Zboril V, Novotny I: A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis. Endoscopy 2003;35:553–558.
Chari ST, Mohan V, Jayanthi V, et al: Comparative profiles of alcoholic chronic pancreatitis and tropical chronic pancreatitis in Tamil Nadu, south India, Panceas 1992;7:52–58.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.